I'm not questioning the partnership with ItalFarmco. The approval of T-Lovenox not only would be a valuable asset for Teva but it's their chance to prove to the market they will be a leader in FOB. Besides Teva is too savvy to play the Lupenox game.
Why is it so implausible that Teva and ItalFarmco are working on a T-Lovenox program that has nothing to do with Lupenox? What about Teva's reputation?